107 related articles for article (PubMed ID: 10753203)
1. Sex-dependent regulation of hepatic peroxisome proliferation in mice by trichloroethylene via peroxisome proliferator-activated receptor alpha (PPARalpha).
Nakajima T; Kamijo Y; Usuda N; Liang Y; Fukushima Y; Kametani K; Gonzalez FJ; Aoyama T
Carcinogenesis; 2000 Apr; 21(4):677-82. PubMed ID: 10753203
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor alpha-mediated pathways are altered in hepatocyte-specific retinoid X receptor alpha-deficient mice.
Wan YJ; Cai Y; Lungo W; Fu P; Locker J; French S; Sucov HM
J Biol Chem; 2000 Sep; 275(36):28285-90. PubMed ID: 10866995
[TBL] [Abstract][Full Text] [Related]
3. Comparison of dose-response relationships for induction of lipid metabolizing and growth regulatory genes by peroxisome proliferators in rat liver.
Belury MA; Moya-Camarena SY; Sun H; Snyder E; Davis JW; Cunningham ML; Vanden Heuvel JP
Toxicol Appl Pharmacol; 1998 Aug; 151(2):254-61. PubMed ID: 9707502
[TBL] [Abstract][Full Text] [Related]
4. The Contribution of Peroxisome Proliferator-Activated Receptor Alpha to the Relationship Between Toxicokinetics and Toxicodynamics of Trichloroethylene.
Yoo HS; Cichocki JA; Kim S; Venkatratnam A; Iwata Y; Kosyk O; Bodnar W; Sweet S; Knap A; Wade T; Campbell J; Clewell HJ; Melnyk SB; Chiu WA; Rusyn I
Toxicol Sci; 2015 Oct; 147(2):339-49. PubMed ID: 26136231
[TBL] [Abstract][Full Text] [Related]
5. Role of the peroxisome proliferator-activated receptor alpha (PPARalpha) in responses to trichloroethylene and metabolites, trichloroacetate and dichloroacetate in mouse liver.
Laughter AR; Dunn CS; Swanson CL; Howroyd P; Cattley RC; Corton JC
Toxicology; 2004 Oct; 203(1-3):83-98. PubMed ID: 15363585
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis of non-responsiveness to peroxisome proliferators: the guinea-pig PPARalpha is functional and mediates peroxisome proliferator-induced hypolipidaemia.
Bell AR; Savory R; Horley NJ; Choudhury AI; Dickins M; Gray TJ; Salter AM; Bell DR
Biochem J; 1998 Jun; 332 ( Pt 3)(Pt 3):689-93. PubMed ID: 9620871
[TBL] [Abstract][Full Text] [Related]
7. PPARalpha agonist-induced rodent tumors: modes of action and human relevance.
Klaunig JE; Babich MA; Baetcke KP; Cook JC; Corton JC; David RM; DeLuca JG; Lai DY; McKee RH; Peters JM; Roberts RA; Fenner-Crisp PA
Crit Rev Toxicol; 2003; 33(6):655-780. PubMed ID: 14727734
[TBL] [Abstract][Full Text] [Related]
8. Human peroxisome proliferator-activated receptor alpha (PPARalpha) supports the induction of peroxisome proliferation in PPARalpha-deficient mouse liver.
Yu S; Cao WQ; Kashireddy P; Meyer K; Jia Y; Hughes DE; Tan Y; Feng J; Yeldandi AV; Rao MS; Costa RH; Gonzalez FJ; Reddy JK
J Biol Chem; 2001 Nov; 276(45):42485-91. PubMed ID: 11551940
[TBL] [Abstract][Full Text] [Related]
9. The peroxisome proliferator-activated receptor alpha (PPARalpha) regulates bile acid biosynthesis.
Hunt MC; Yang YZ; Eggertsen G; Carneheim CM; Gåfvels M; Einarsson C; Alexson SE
J Biol Chem; 2000 Sep; 275(37):28947-53. PubMed ID: 10867000
[TBL] [Abstract][Full Text] [Related]
10. In vivo stabilization of nuclear retinoid X receptor alpha in the presence of peroxisome proliferator-activated receptor alpha.
Tanaka N; Hora K; Makishima H; Kamijo Y; Kiyosawa K; Gonzalez FJ; Aoyama T
FEBS Lett; 2003 May; 543(1-3):120-4. PubMed ID: 12753917
[TBL] [Abstract][Full Text] [Related]
11. Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha.
Cheung C; Akiyama TE; Ward JM; Nicol CJ; Feigenbaum L; Vinson C; Gonzalez FJ
Cancer Res; 2004 Jun; 64(11):3849-54. PubMed ID: 15172993
[TBL] [Abstract][Full Text] [Related]
12. Cell cross-talk mediates PPARalpha null hepatocyte proliferation after peroxisome proliferator exposure.
Weglarz TC; Sandgren EP
Carcinogenesis; 2004 Jan; 25(1):107-12. PubMed ID: 14514660
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor alpha is restricted to hepatic parenchymal cells, not Kupffer cells: implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis.
Peters JM; Rusyn I; Rose ML; Gonzalez FJ; Thurman RG
Carcinogenesis; 2000 Apr; 21(4):823-6. PubMed ID: 10753222
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the role of peroxisome proliferator-activated receptor alpha (PPARalpha) in mouse liver tumor induction by trichloroethylene and metabolites.
Corton JC
Crit Rev Toxicol; 2008; 38(10):857-75. PubMed ID: 18821149
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
Peters JM; Zhou YC; Ram PA; Lee SS; Gonzalez FJ; Waxman DJ
Mol Pharmacol; 1996 Jul; 50(1):67-74. PubMed ID: 8700121
[TBL] [Abstract][Full Text] [Related]
16. Fibrate-modulated expression of fibrinogen, plasminogen activator inhibitor-1 and apolipoprotein A-I in cultured cynomolgus monkey hepatocytes -- role of the peroxisome proliferator-activated receptor-alpha.
Kockx M; Princen HM; Kooistra T
Thromb Haemost; 1998 Dec; 80(6):942-8. PubMed ID: 9869165
[TBL] [Abstract][Full Text] [Related]
17. trans-Activation of PPARalpha and PPARgamma by structurally diverse environmental chemicals.
Maloney EK; Waxman DJ
Toxicol Appl Pharmacol; 1999 Dec; 161(2):209-18. PubMed ID: 10581215
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting.
Kersten S; Seydoux J; Peters JM; Gonzalez FJ; Desvergne B; Wahli W
J Clin Invest; 1999 Jun; 103(11):1489-98. PubMed ID: 10359558
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of rat oval cells after activation of peroxisome proliferator-activated receptor alpha43.
Kaplanski C; Pauley CJ; Griffiths TG; Kawabata TT; Ledwith BJ
Cancer Res; 2000 Feb; 60(3):580-7. PubMed ID: 10676640
[TBL] [Abstract][Full Text] [Related]
20. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
